BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2638122)

  • 1. Biochemical pharmacological profile of migraine prophylactics of pizotifen type.
    Dlohozková N; Metys J; Valchár M; Soucek R
    Act Nerv Super (Praha); 1989 Dec; 31(4):300-1. PubMed ID: 2638122
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiserotonin agents in the treatment of migraine.
    Prusiński A; Klimek A
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):189-93. PubMed ID: 1107969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimigraine drug interactions with 5-hydroxytryptamine1A receptors.
    Hiner BC; Roth HL; Peroutka SJ
    Ann Neurol; 1986 May; 19(5):511-3. PubMed ID: 2940961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin precursors in migraine prophylaxis.
    Bono G; Criscuoli M; Martignoni E; Salmon S; Nappi G
    Adv Neurol; 1982; 33():357-63. PubMed ID: 7034490
    [No Abstract]   [Full Text] [Related]  

  • 5. [Etiology and treatment of migraine].
    Petelin LS; Shtok VN; Pigarev VA
    Sov Med; 1976 Nov; (11):62-5. PubMed ID: 1006395
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the effect of a single dose of pizotifen on the electro-encephalographic pattern in healthy persons and in patients afflicted with migraine.
    Prusiński A; Dzialek E; Klimek A; Kurp F
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):183-7. PubMed ID: 1208227
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of pizotifen and ergotamine on the venoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man.
    Aellig WH
    Eur J Clin Pharmacol; 1983; 25(6):759-62. PubMed ID: 6662174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toleration and effectiveness of pizotifen in migraine.
    Mikropoulos HE
    Res Clin Stud Headache; 1978; 6():167-72. PubMed ID: 725252
    [No Abstract]   [Full Text] [Related]  

  • 9. [Basic treatment of migraine. Value of pizotifen (BC105)].
    Neuman M
    Med Chir Dig; 1975; 4(5-6):323. PubMed ID: 1207214
    [No Abstract]   [Full Text] [Related]  

  • 10. Pizotifen in the treatment of migraine.
    Heathfield KW; Stone P; Crowder D
    Practitioner; 1977 Mar; 218(1305):428-30. PubMed ID: 322111
    [No Abstract]   [Full Text] [Related]  

  • 11. Pizotifen in the management of migraine.
    Bademosi O; Osuntokun BO
    Practitioner; 1978 Feb; 220(1316):325-7. PubMed ID: 345259
    [No Abstract]   [Full Text] [Related]  

  • 12. Further experience with pizotifen in the treatment of migraine.
    Foster JB
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):66-9. PubMed ID: 812667
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of the new antiserotonin preparations, sandomigran and lizenil, in treating patients suffering from migraine].
    Matevosian AA
    Zh Eksp Klin Med; 1976; 16(5):95-100. PubMed ID: 799448
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects on arterial receptors of ergot derivatives used in migraine.
    Müller-Schweinitzer E; Fanchamps A
    Adv Neurol; 1982; 33():343-56. PubMed ID: 6275676
    [No Abstract]   [Full Text] [Related]  

  • 15. Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation.
    Vilming S; Standnes B; Hedman C
    Cephalalgia; 1985 Mar; 5(1):17-23. PubMed ID: 3986895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonists and antagonists of 5-hydroxytryptamine on venomotor receptors.
    Aellig WH
    Adv Neurol; 1982; 33():321-4. PubMed ID: 7055012
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of serotonin antagonists in a behavioral despair procedure in mice.
    Luttinger D; Freedman M; Hamel L; Ward SJ; Perrone M
    Eur J Pharmacol; 1984 Dec; 107(1):53-8. PubMed ID: 6526071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen).
    Dixon AK; Hill RC; Roemer D; Scholtysik G
    Arzneimittelforschung; 1977; 27(10):1968-79. PubMed ID: 411500
    [No Abstract]   [Full Text] [Related]  

  • 19. Fulminant hepatitis possibly related to pizotifen therapy.
    Elouni B; Ben Salem C; Zamy M; Poupon R; Bouraoui K; Biour M
    Ann Pharmacother; 2010; 44(7-8):1348-9. PubMed ID: 20571104
    [No Abstract]   [Full Text] [Related]  

  • 20. Pizotifen, an antimigraine drug with venoconstrictor activity in vivo.
    Müller-Schweinitzer E
    J Cardiovasc Pharmacol; 1986; 8(4):805-10. PubMed ID: 2427822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.